Work

Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group.

Year: 2014

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: PubMed

Authors: Vasilios Karavasilis, Paris Kosmidis, Konstantinos N Syrigos, Polyxeni Mavropoulou, Meletios A Dimopoulos, Vassiliki Kotoula, Dimitrios Pectasides, Ioannis Boukovinas, George Klouvas, Anna Kalogera-Fountzila, Christos N Papandreou, George Fountzilas, Evangelos Briasoulis

Institutions: Aristotle University of Thessaloniki, Papageorgiou General Hospital, Hygeia Hospital, Sotiria General Hospital, AHEPA University Hospital, National and Kapodistrian University of Athens, Alexandra Hospital, Hippocration General Hospital, Theageneio General Hospital, Metropolitan Hospital, University of Thessaly, University Hospital of Larissa, University of Ioannina

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2183863864

FWCI: 1.453

Cites: 15

Cited by: 10

Related to: 10